BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6348187)

  • 21. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L; Korányi L; Tamás G
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2 diabetes mellitus among children and adolescents in Al-Ain: a case series.
    Punnose J; Agarwal MM; Bin-Uthman S
    East Mediterr Health J; 2005 Jul; 11(4):788-97. PubMed ID: 16700395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Usefulness of the determination of C-peptide and proinsulin in the extrahepatic serum for the evaluation of the function of the B cells of the islands of Langerhans].
    Czyzyk A
    Pol Arch Med Wewn; 1983; 69(4-5):249-57. PubMed ID: 6356053
    [No Abstract]   [Full Text] [Related]  

  • 24. [Determination of plasmatic C-peptide and its clinical uses].
    Cautela G; Barbero PL; Gamba S; Regis G; Bruni B
    Ann Osp Maria Vittoria Torino; 1978; 21(7-12):203-37. PubMed ID: 399164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urinalysis of school children for the screening of juvenile diabetes mellitus (for 3 consecutive years in a single area) and C-peptide secretory capacity during 50g glucose loading].
    Mano T; Fujita H
    Horumon To Rinsho; 1977 Sep; 25(9):964-73. PubMed ID: 923121
    [No Abstract]   [Full Text] [Related]  

  • 26. Perinatal islet function in gestational diabetes: assessment by cord plasma C-peptide and amniotic fluid insulin.
    Ogata ES; Freinkel N; Metzger BE; Phelps RL; Depp R; Boehm JJ; Dooley SL
    Diabetes Care; 1980; 3(3):425-9. PubMed ID: 6993160
    [No Abstract]   [Full Text] [Related]  

  • 27. [Function of the islands of Langerhans and the course of diabetes mellitus in children].
    Kniazev IuA; Vakhrusheva LL; Demidova LV; Kuznetsova NN
    Pediatriia; 1981 Oct; (10):10-2. PubMed ID: 7031587
    [No Abstract]   [Full Text] [Related]  

  • 28. [Incidence of clinical remission and residual beta function during early stages of diabetes mellitus type I (author's transl)].
    Peig M; Reynals E; Gomis R; Millán M; Casamitjana R; Figuerola D
    Med Clin (Barc); 1982 Feb; 78(3):81-3. PubMed ID: 7043122
    [No Abstract]   [Full Text] [Related]  

  • 29. Circulating C peptide: measurement and clinical application.
    Ashby JP; Frier BM
    Ann Clin Biochem; 1981 May; 18(Pt 3):125-30. PubMed ID: 7025731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial preservation of pancreatic beta-cell function in children with diabetes.
    Elliott RB; Crossley JR; Berryman CC; James AG
    Lancet; 1981 Jul; 2(8236):1-4. PubMed ID: 6113394
    [No Abstract]   [Full Text] [Related]  

  • 31. [Remissions of diabetes in children].
    Otto-Buczkowska E
    Pol Tyg Lek; 1971 Oct; 26(40):1540-1. PubMed ID: 4940326
    [No Abstract]   [Full Text] [Related]  

  • 32. Partial preservation of pancreatic beta-cell function in children with diabetes.
    Lancet; 1981 Aug; 2(8241):311. PubMed ID: 6114355
    [No Abstract]   [Full Text] [Related]  

  • 33. C-peptide an adequate endpoint in type 1 diabetes.
    Ludvigsson J
    Diabetes Metab Res Rev; 2009 Nov; 25(8):691-3. PubMed ID: 19877135
    [No Abstract]   [Full Text] [Related]  

  • 34. Factors influencing residual pancreatic beta cell function in recently diagnosed Type 1 diabetic children.
    Hill MA; Court JM
    Aust Paediatr J; 1982 Mar; 18(1):37-9. PubMed ID: 7049145
    [No Abstract]   [Full Text] [Related]  

  • 35. [C-peptide and the importance of its determination].
    Perusicová J; Skachová J
    Vnitr Lek; 1986 Jun; 32(6):587-91. PubMed ID: 3739250
    [No Abstract]   [Full Text] [Related]  

  • 36. C-Peptide and the remission phase of juvenile diabetes.
    Block MB
    Diabetes Care; 1978; 1(5):330. PubMed ID: 720188
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experience with the work of a summer sanatorium for children with diabetes mellitus].
    Bashliaeva ZA; Kniazev IuA; Korosteleva NA; Voichik EA; Trofimenko LS
    Vopr Okhr Materin Det; 1971 Apr; 16(4):77-9. PubMed ID: 5137816
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of sanatorium for children with diabetes].
    Margolis A; Bugalowa I; Nowicki S; Olszowska L
    Pediatr Pol; 1968 Mar; 43(3):373-9. PubMed ID: 5663211
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical significance of C-peptide.
    Rubenstein AH; Gonen B
    Adv Exp Med Biol; 1979; 124():15-28. PubMed ID: 506831
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experience with the use of therapeutic exercise in the complex sanatorium treatment of children with diabetes mellitus].
    Estrina IA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1971; 36(4):336-40. PubMed ID: 5151595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.